Study for Efficacy and Dose Escalation of AD313 + Atomoxetine (SEED)
Condition:   Obstructive Sleep Apnea Interventions:   Drug: Dosing 1: Atomoxetine;   Drug: Dosing 2-4: AD313 Sponsor:   Apnimed Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2021 Category: Research Source Type: clinical trials

Measuring Atomoxetine and Aroxybutinin In Patients With OSA
Condition:   Obstructive Sleep Apnea (OSA) Interventions:   Drug: AD109 (atomoxetine/aroxybutynin);   Drug: Atomoxetine Hydrochloride;   Drug: Placebo Sponsor:   Apnimed Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 25, 2021 Category: Research Source Type: clinical trials